BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 12319124)

  • 1. Why isn't increased survival enough?
    Wilson A
    Integration; 1994 Dec; (42):12-5. PubMed ID: 12319124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zimbabwe: are the costs of AIDS medical care affordable?
    Hore R
    AIDS Anal Afr; 1993; 3(2):6-8. PubMed ID: 12318404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Economic costs of HIV infection: an employer's perspective.
    Liu GG; Yin DD; Lyu R; Chaikledkaew U; Louie S
    Eur J Health Econ; 2002; 3(4):226-34. PubMed ID: 15609147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The 400-million-dollar cost. Brazil.
    Cardoso R
    Integration; 1998; (57):16-7. PubMed ID: 12294618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing and alleviating the real impact of AIDS.
    Bertozzi S
    Glob AIDSnews; 1995; (1):10-1. PubMed ID: 12346159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolonged enoxaparin therapy to prevent venous thromboembolism after primary hip or knee replacement. A cost-utility analysis.
    Haentjens P; De Groote K; Annemans L
    Arch Orthop Trauma Surg; 2004 Oct; 124(8):507-17. PubMed ID: 15365714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protease inhibitor combination therapy, severity of illness, and quality of life among children with perinatally acquired HIV-1 infection.
    Storm DS; Boland MG; Gortmaker SL; He Y; Skurnick J; Howland L; Oleske JM;
    Pediatrics; 2005 Feb; 115(2):e173-82. PubMed ID: 15629958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adding the human dimension to economic analysis: why DALYs don't tell the whole story.
    Bertozzi S
    AIDS Anal Afr; 1994; 4(5):7-8, 15. PubMed ID: 12287911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The direct costs of HIV / AIDS in a South African sugar mill.
    Morris CN; Cheevers EJ
    AIDS Anal Afr; 2000; 10(5):7-8. PubMed ID: 12322488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Family pediatrics: report of the Task Force on the Family.
    Schor EL;
    Pediatrics; 2003 Jun; 111(6 Pt 2):1541-71. PubMed ID: 12777595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Socio-economic impact of antiretroviral treatment in HIV patients. An economic review of cost savings after introduction of HAART.
    Gonzalo T; García Goñi M; Muñoz-Fernández MA
    AIDS Rev; 2009; 11(2):79-90. PubMed ID: 19529748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.
    Griebsch I; Coast J; Brown J
    Pediatrics; 2005 May; 115(5):e600-14. PubMed ID: 15867026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacoeconomics.
    Sule NS; Nerurkar RP; Kamath SA
    J Assoc Physicians India; 2002 Aug; 50():1057-62. PubMed ID: 12421032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Savings can be achieved if Ugandan company provides HIV drugs to employees.
    AIDS Wkly; 2000 Jul; ():17-8. PubMed ID: 12322550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The economic impact of AIDS in Africa.
    Wehrwein P
    Harv AIDS Rev; 2000; ():12-4. PubMed ID: 12322292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [AIDS in children, another public health problem].
    Cruz Bournigal ES
    Arch Domin Pediatr; 1990; 26(2):37. PubMed ID: 12347258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mandela calls for greater commitment and leadership in fighting AIDS. The World Economic Forum -- Policy and business in a world of HIV / AIDS.
    Macinnis R
    AIDSlink; 1997; (43):1, 3. PubMed ID: 12321752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health care quality versus economics in HIV.
    Torres G
    GMHC Treat Issues; 1996; 10(6/7):17, 19-20. PubMed ID: 11363637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The economics of effective AIDS treatment in Thailand.
    Over M; Revenga A; Masaki E; Peerapatanapokin W; Gold J; Tangcharoensathien V; Thanprasertsuk S
    AIDS; 2007 Jul; 21 Suppl 4():S105-16. PubMed ID: 17620745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Economic impact of cardiac resynchronization therapy in patients with heart failure. Available evidence and evaluation of the CRT-Eucomed model for analysis of cost-effectiveness].
    Fattore G; Landolina M; Bontempi L; Cacciatore G; Curnis A; Gulizia M; Padeletti L; Mazzei L; Tavazzi L;
    Ital Heart J Suppl; 2005 Dec; 6(12):796-803. PubMed ID: 16444923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.